Stryker Corporation

Healthcare · Medical Devices

277.00$ +0.6% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

Stryker Corporation (SYK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 6,589 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SYK
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	2,833	3,157	2,955	3,012	3,006	3,471	3,241	3,322	3,242	3,796	3,516	3,650	3,587	4,131	3,588	2,764	3,737	4,262	3,953	4,294	4,160	4,701	4,275	4,493	4,479	5,202	4,778	4,996	4,909	5,815	5,243	5,422	5,494	6,436	5,866	6,022	6,057	7,171	6,020	6,589	25,837
Cost of Revenue	1,045	1,153	1,081	1,117	1,116	1,326	1,206	1,242	1,199	1,419	1,347	1,392	1,375	1,504	1,375	1,326	1,390	1,618	1,547	1,611	1,539	1,773	1,684	1,807	1,829	2,130	1,908	1,958	1,889	2,261	2,049	2,098	2,101	2,447	2,186	2,272	2,205	2,494	2,210	2,091	9,000
Gross Profit	1,788	2,004	1,874	1,895	1,890	2,145	2,035	2,080	2,043	2,377	2,169	2,258	2,212	2,627	2,213	1,438	2,347	2,644	2,406	2,683	2,621	2,928	2,591	2,686	2,650	3,072	2,870	3,038	3,020	3,554	3,194	3,324	3,393	3,989	3,680	3,750	3,852	4,677	3,810	4,498	16,837
Research & Development	184	189	192	192	198	205	204	216	221	221	225	246	246	254	254	233	242	255	288	310	306	331	306	323	317	284	311	319	335	328	356	352	364	342	393	396	410	401	413	434	1,658
Selling, General & Administrative	1,057	1,093	1,102	1,130	1,103	1,217	1,236	1,190	1,242	1,431	1,403	1,282	1,291	1,380	1,330	1,225	1,244	1,562	1,575	1,505	1,419	1,507	1,710	1,539	1,455	1,593	1,781	1,706	1,701	1,941	1,840	1,847	1,896	2,102	2,300	1,993	2,045	2,135	2,281	2,229	8,690
Total Operating Expenses	1,171	1,282	1,251	1,245	1,257	1,382	1,339	1,337	1,350	1,461	1,437	1,438	1,460	1,590	1,499	1,230	1,428	1,548	1,678	1,746	1,725	1,838	1,807	1,780	1,801	1,877	2,012	1,974	2,029	2,129	2,191	2,166	2,185	2,326	2,501	2,389	2,717	2,716	2,874	2,839	11,146
Operating Income	617	722	623	650	633	763	696	743	693	916	732	820	752	1,037	714	208	919	1,096	728	937	896	1,090	784	906	849	1,195	858	1,064	991	1,425	1,003	1,158	1,208	1,663	1,179	1,361	1,135	1,961	936	1,659	5,691
Interest Expense	0.0	228	0.0	0.0	0.0	247	264	264	264	264	287	287	287	287	–	–	–	–	–	–	–	–	61	52	8.0	53	56	–	–	–	–	–	–	–	137	159	157	381	148	141	827
Pre-Tax Income	419	588	499	444	471	649	542	623	534	657	480	565	581	936	590	-87	780	671	367	662	495	757	386	720	816	761	679	899	869	1,226	923	998	1,043	528	764	1,016	1,029	1,705	850	1,564	5,148
Income Tax Expense	64	78	55	53	37	898	99	171	-56	-1,411	68	85	115	211	97	-4.0	159	103	65	70	57	95	63	64	-8.0	198	87	161	177	83	135	173	209	-18	110	132	170	856	105	288	1,419
Net Income	355	510	444	391	434	-249	443	452	590	2,068	412	480	466	725	493	-83	621	568	302	592	438	662	323	656	816	563	592	738	692	1,143	788	825	834	546	654	884	859	849	745	1,276	3,729
EBITDA	567	739	649	604	634	748	718	809	719	794	670	764	775	1,131	788	106	978	894	643	903	730	1,329	628	973	1,066	1,014	936	1,158	1,131	1,476	1,183	1,256	1,311	792	1,036	1,471	1,363	2,030	1,298	1,564	6,255

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings